FDA Aims to Destigmatize Drugs as Treatment for Opioid Addiction
- Agency looks to broaden use of ‘medication-assisted’ therapy
- Commissioner: Opponents use ‘flawed interpretation of science’
How America's Opioid Crisis Spiraled Out of Control
This article is for subscribers only.
As the opioid epidemic in the U.S. continues to kill more and more Americans, the Food and Drug Administration wants to lift the stigma on the idea of using drugs to treat a drug habit.
FDA Commissioner Scott Gottlieb told a U.S. House committee on Wednesday that his agency is looking at ways to broaden the use of “medication-assisted therapy,” or the use of drugs such as methadone and buprenorphine, in conjunction with counseling, to help people overcome addiction to opioids.